Delineation for oral cavity and oropharyngeal cancers;Délinéation des cancers de la cavité buccale et de l'oropharynx

Cancer/Radiotherapie

Volumn 17, Issue 5-6, 2013, Pages 493-497

  Lapeyre, M ^a   Loos, G ^a   Biau, J ^a  

^a CENTRE JEAN PERRIN   (France)

Author keywords

Cancer; Delineation; IMRT; Oral cavity; Oropharynx; Radiotherapy

Indexed keywords

FLUORODEOXYGLUCOSE;

CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; HEAD; HUMAN; MOUTH CAVITY; NECK; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SHORT SURVEY; TUMOR VOLUME;

CANCER; CAVITÉ BUCCALE; DÉLINÉATION; DELINEATION; IMRT; ORAL CAVITY; OROPHARYNX; RADIOTHÉRAPIE; RADIOTHERAPY; RCMI;

DIAGNOSTIC IMAGING; HUMANS; MOUTH NEOPLASMS; ORGANS AT RISK; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84884353274     PISSN: 12783218     EISSN: 17696658     Source Type: Journal    
DOI: 10.1016/j.canrad.2013.05.007     Document Type: Short Survey

References (47)

1. Toledano I., Graff P., Serre A., Boisselier P., Bensadoun R.J., Ortholan C., et al. Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004-03. Radiother Oncol 2012, 103:57-62.
2. Nutting C.M., Morden J.P., Harrington K.J., Urbano T.G., Bhide S.A., Clark C., et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3multicentre randomised controlled trial. Lancet Oncol 2011, 12:127-136.
3. Gupta T., Agarwal J., Jain S., Phurailatpam R., Kannan S., Ghosh-Laskar S., et al. Three-dimensional conformal radiotherapy (3D-CRT) versus intensity modulated radiation therapy (IMRT) in squamous cell carcinoma of the head and neck: a randomized controlled trial. Radiother Oncol 2012, 104:343-348.
4. Sher D.J., Thotakura V., Balboni T.A., Norris C.M., Haddad R.I., Posner M.R., et al. Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapy. Ann Oncol 2012, 23:2391-2398.
5. Studer G., Brown M., Bredell M., Graetz K.W., Huber G., Linsenmeier C., et al. Follow-up after IMRT in oral cavity cancer: update. Radiat Oncol 2012, 7:84.
6. Lapeyre M., Toledano I., Bourry N., Bailly C., Cachin F. Délinéation des volumes cibles des cancers des voies aérodigestives supérieures en radiothérapie conformationnelle avec modulation d'intensité. Cancer Radiother 2011, 15:466-472.
7. Chao K.S., Wippold F.J., Ozyigit G., Tran B.N., Dempsey J.F. Determination and delineation of nodal target volumes for head-and-neck cancer based on patterns of failure in patients receiving definitive and postoperative IMRT. Int J Radiat Oncol Biol Phys 2002, 53:1174-1184.
8. Chao K.S.C., Apisarnthanarax S., Ozyigit G. Practical essentials of intensity modulated radiation therapy 2005, Lippincott, Philadelphia.
9. Eisbruch A., Foote R.L., O'Sullivan B., Beitler J.J., Vikram B. Intensity-modulated radiation therapy for head and neck cancer: emphasis on the selection and delineation of the targets. Semin Radiat Oncol 2002, 12:238-249.
10. Grégoire V., Coche E., Cosnard G., Hamoir M., Reychler H. Selection and delineation of lymph node target volumes in head and neck conformal radiotherapy. Proposal for standardizing terminology and procedure based on the surgical experience. Radiother Oncol 2000, 56:135-150.
11. Grégoire V., Eisbruch A., Hamoir M., Levendag P. Proposal for the delineation of the nodal CTV in the node-positive and the post-operative neck. Radiother Oncol 2006, 79:15-20.
12. Grégoire V., Levendag P., Ang K.K., Bernier J., Braaksma M., Budach V., et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 2003, 69:227-236.
13. Hansen E.K., Roach M. Handbook of evidence-based radiation oncology 2010, Springer, New York.
14. Lapeyre M., Henrot P., Alfonsi M., Bardet E., Bensadoun R.J., Dolivet G., et al. Proposition de sélection et délimitation des volumes cibles microscopiques péritumoraux dans les cancers de la cavité buccale et de l'oropharynx (aires ganglionnaires exclues). Cancer Radiother 2005, 9:261-270.
15. Levendag P., Al-Mamgani A., Teguh D. Contouring in head & neck cancer 2009, Elsevier, Munich.
16. Grégoire V., Daisne J.F., Bauvois C., Coche E., Duprez T., Hamoir M., et al. Sélection et délimitation des volumes cibles anatomocliniques ganglionnaires dans les tumeurs de la sphère cervico-maxillo-faciale. Cancer Radiother 2001, 5:614-628.
17. ICRU Prescribing, recording, and reporting photon beam therapy, report 50 1993, ICRU, Bethesda, MD.
18. ICRU Prescibing, recording, and reporting photon beam therapy, report 62 1999, ICRU, Bethesda, MD.
19. ICRU Prescribing, Recording, and Reporting Photon-Beam Intensity-Modulated Radiation Therapy (IMRT) Report 83. Journal of the ICRU 2010, 10.
20. Gardner M., Halimi P., Valinta D., Plantet M.M., Alberini J.L., Wartski M., et al. Use of single MRI and 18F-FDG PET-CT scans in both diagnosis and radiotherapy treatment planning in patients with head and neck cancer: advantage on target volume and critical organ delineation. Head Neck 2009, 31:461-467.
21. Lenz M., Greess H., Baum U., Dobritz M., Kersting-Sommerhoff B. Oropharynx, oral cavity, floor of the mouth: CT and MRI. Eur J Radiol 2000, 33:203-215.
22. Schinagl D.A., Vogel W.V., Hoffmann A.L., van Dalen J.A., Oyen W.J., Kaanders J.H. Comparison of five segmentation tools for 18F-fluoro-deoxy-glucose-positron emission tomography-based target volume definition in head and neck cancer. Int J Radiat Oncol Biol Phys 2007, 69:1282-1289.
23. Schinagl D.A., Hoffmann A.L., Vogel W.V., van Dalen J.A., Verstappen S.M., Oyen W.J., et al. Can FDG-PET assist in radiotherapy target volume definition of metastatic lymph nodes in head-and-neck cancer?. Radiother Oncol 2009, 91:95-100.
24. Geets X., Lee J.A., Castadot P., Bol A., Grégoire V. RÔle potentiel de la TEP-FDG pour la définition du volume tumoral macroscopique (GTV) des cancers des voies aérodigestives supérieures et du poumon. Cancer Radiother 2009, 13:594-599.
25. Grégoire V., Bol A., Geets X., Lee J. Is PET-based treatment planning the new standard in modern radiotherapy? The head and neck paradigm. Semin Radiat Oncol 2006, 16:232-238.
26. Salama J.K., Haddad R.I., Kies M.S., Busse P.M., Dong L., Brizel D.M., et al. Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009, 75:725-733.
27. Eisbruch A., Harris J., Garden A.S., Chao C.K., Straube W., Harari P.M., et al. Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00-22). Int J Radiat Oncol Biol Phys 2010, 76:1333-1338.
28. Apisarnthanarax S., Elliott D.D., El-Naggar A.K., Asper J.A., Blanco A., Ang K.K., et al. Determining optimal clinical target volume margins in head-and-neck cancer based on microscopic extracapsular extension of metastatic neck nodes. Int J Radiat Oncol Biol Phys 2006, 64:678-683.
29. Ghadjar P., Schreiber-Facklam H., Grater R., Evers C., Simcock M., Geretschlager A., et al. Quantitative analysis of extracapsular extension of metastatic lymph nodes and its significance in radiotherapy planning in head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2010, 76:1127-1132.
30. Vorwerk H., Hess C.F. Guidelines for delineation of lymphatic clinical target volumes for high conformal radiotherapy: head and neck region. Radiat Oncol 2011, 6:97.
31. Stroom J.C., de Boer H.C., Huizenga H., Visser A.G. Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability. Int J Radiat Oncol Biol Phys 1999, 43:905-919.
32. van Herk M., Remeijer P., Lebesque J.V. Inclusion of geometric uncertainties in treatment plan evaluation. Int J Radiat Oncol Biol Phys 2002, 52:1407-1422.
33. Astreinidou E., Bel A., Raaijmakers C.P., Terhaard C.H., Lagendijk J.J. Adequate margins for random setup uncertainties in head-and-neck IMRT. Int J Radiat Oncol Biol Phys 2005, 61:938-944.
34. Gulliford S.L., Miah A.B., Brennan S., McQuaid D., Clark C.H., Partridge M., et al. Dosimetric explanations of fatigue in head and neck radiotherapy: an analysis from the PARSPORT Phase III trial. Radiother Oncol 2012, 104:205-212.
35. Marchand V., Dendale R. Dose de tolérance à l'irradiation des tissus sains: l'œil. Cancer Radiother 2010, 14:277-283.
36. Berger A., Bensadoun R.J. Dose de tolérance à l'irradiation des tissus sains: la mandibule. Cancer Radiother 2010, 14:295-300.
37. Fleury B., Lapeyre M. Dose de tolérance à l'irradiation des tissus sains: l'oreille. Cancer Radiother 2010, 14:284-289.
38. Haberer S., Assouline A., Mazeron J.J. Dose de tolérance à l'irradiation des tissus sains: encéphale et hypophyse. Cancer Radiother 2010, 14:263-268.
39. Alevronta E., Ahlberg A., Mavroidis P., al-Abany M., Friesland S., Tilikidis A., et al. Dose-response relations for stricture in the proximal oesophagus from head and neck radiotherapy. Radiother Oncol 2010, 97:54-59.
40. Debelleix C., Pointreau Y., Lafond C., Denis F., Calais G., Bourhis J.H. Dose de tolérance à l'irradiation des tissus sains: larynx et pharynx. Cancer Radiother 2010, 14:301-306.
41. Christianen M.E., Langendijk J.A., Westerlaan H.E., van de Water T.A., Bijl H.P. Delineation of organs at risk involved in swallowing for radiotherapy treatment planning. Radiother Oncol 2011, 101:394-402.
42. Habrand J.L., Drouet F. Dose de tolérance à l'irradiation des tissus sains: moelle épinière. Cancer Radiother 2010, 14:269-276.
43. Hall W.H., Guiou M., Lee N.Y., Dublin A., Narayan S., Vijayakumar S., et al. Development and validation of a standardized method for contouring the brachial plexus: preliminary dosimetric analysis among patients treated with IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 2008, 72:1362-1367.
44. Berges O., Belkacémi Y., Giraud P. Dose de tolérance à l'irradiation des tissus sains: la thyroïde. Cancer Radiother 2010, 14:307-311.
45. Ortholan C., Benezery K., Bensadoun R.J. Dose de tolérance à l'irradiation des tissus sains: les glandes salivaires. Cancer Radiother 2010, 14:290-294.
46. van de Water T.A., Bijl H.P., Westerlaan H.E., Langendijk J.A. Delineation guidelines for organs at risk involved in radiation-induced salivary dysfunction and xerostomia. Radiother Oncol 2009, 93:545-552.
47. McKenzie A., van Herk M., Mijnheer B. Margins for geometric uncertainty around organs at risk in radiotherapy. Radiother Oncol 2002, 62:299-307.